An anonymous trustee reports

DRI HEALTHCARE TRUST DECLARES SPECIAL UNIT DISTRIBUTION

In accordance with the requirement for the trust to distribute all of its taxable income for the year, DRI Healthcare Trust's board of trustees has declared a special unit distribution of 2.37 U.S. cents per unit. The special unit distribution will be made payable to unitholders of record at the close of business on Dec. 31, 2024. This special unit distribution is in addition to the quarterly cash distribution declared on Nov. 6, 2024, of 8.5 U.S. cents per unit.

Immediately after the issuance of such units in satisfaction of the special unit distribution effective Dec. 31, 2024, the number of outstanding units of the trust will be consolidated such that the total number of units outstanding will not change, and each unitholder will hold the same number of units following such distribution as were held immediately prior. Each unitholder of record on Dec. 31, 2024, will be entitled to add the amount of the special unit distribution to their adjusted cost base of units of the trust as at Dec. 31, 2024. For the avoidance of doubt, this unit distribution will be a non-cash transaction.

The total amount of cash that will have been returned to the trust's unitholders through the quarterly distributions and the normal course issuer bid in 2024 will be approximately $23.1-million (U.S.).

About DRI Healthcare Trust

The trust is managed by DRI Capital Inc., the pioneer in global pharmaceutical royalty monetization. Since its initial public offering in 2021, the trust has deployed more than $1-billion (U.S.), acquiring more than 25 royalties on greater than 20 drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga.